16-11896676-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002094.4(GSPT1):āc.546G>Cā(p.Glu182Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,608,286 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002094.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSPT1 | NM_002094.4 | c.546G>C | p.Glu182Asp | missense_variant | 4/15 | ENST00000434724.7 | NP_002085.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSPT1 | ENST00000434724.7 | c.546G>C | p.Glu182Asp | missense_variant | 4/15 | 1 | NM_002094.4 | ENSP00000398131.2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000134 AC: 32AN: 239364Hom.: 1 AF XY: 0.000162 AC XY: 21AN XY: 129588
GnomAD4 exome AF: 0.000133 AC: 193AN: 1456084Hom.: 1 Cov.: 30 AF XY: 0.000152 AC XY: 110AN XY: 723694
GnomAD4 genome AF: 0.000118 AC: 18AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.546G>C (p.E182D) alteration is located in exon 4 (coding exon 4) of the GSPT1 gene. This alteration results from a G to C substitution at nucleotide position 546, causing the glutamic acid (E) at amino acid position 182 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at